✦ LIBER ✦

P972 A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia

✍ Scribed by A.J. Ullmann; J. De Waele; R. Betts; C. Rotstein; M. Nucci; O.A. Cornely

Book ID: 119564954
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 60 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(07)70813-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of candidemia and invasive can

Treatment of candidemia and invasive candidiasis in the intensive care unit:post hocanalysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

✍ Bertrand F Dupont,Olivier Lortholary,Luis Ostrosky-Zeichner… 📂 Article 📅 2009 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 282 KB

PIN16 COST-EFFECTIVENESS ANALYSIS OF MIC

PIN16 COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B IN THE TREATMENT OF PAEDIATRIC PATIENTS WITH SYSTEMIC CANDIDA INFECTIONS

✍ A Odeyemi; WM Hart; II Odeyemi; P Musingarimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

P980 Liposomal amphotericin B standard d

P980 Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocom-promised patients: randomised pilot study (Combistrat Trial)

✍ D. Caillot; A. Thiébaut; R. Herbrecht; A. Pigneux; S. de Botton; M. Attal; F. Be 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy and safety results from a phase

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Efficacy and safety of darunavir-ritonav

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

✍ José Valdez Madruga; Daniel Berger; Marilyn McMurchie; Fredy Suter; Denes Banheg 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis : A prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer

✍ Rene-Jean Bensadoun; Jamel Daoud; Brahim El Gueddari; Laurent Bastit; Rene Gourm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr